Zimmer Accounts Payable vs Total Current Liabilities Analysis
ZBH Stock | USD 115.15 0.71 0.62% |
Zimmer Biomet financial indicator trend analysis is more than just analyzing Zimmer Biomet Holdings current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Zimmer Biomet Holdings is a good investment. Please check the relationship between Zimmer Biomet Accounts Payable and its Total Current Liabilities accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Accounts Payable vs Total Current Liabilities
Accounts Payable vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Zimmer Biomet Holdings Accounts Payable account and Total Current Liabilities. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Zimmer Biomet's Accounts Payable and Total Current Liabilities is 0.91. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Zimmer Biomet Holdings, assuming nothing else is changed. The correlation between historical values of Zimmer Biomet's Accounts Payable and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Zimmer Biomet Holdings are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Accounts Payable i.e., Zimmer Biomet's Accounts Payable and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | 0.91 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Accounts Payable
An accounting item on the balance sheet that represents Zimmer Biomet obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Zimmer Biomet Holdings are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Total Current Liabilities
Total Current Liabilities is an item on Zimmer Biomet balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Zimmer Biomet Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Zimmer Biomet's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Zimmer Biomet Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. As of now, Zimmer Biomet's Tax Provision is increasing as compared to previous years. The Zimmer Biomet's current Enterprise Value Over EBITDA is estimated to increase to 15.40, while Selling General Administrative is projected to decrease to under 2 B.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 4.9B | 4.9B | 4.7B | 3.6B | Total Revenue | 6.8B | 6.9B | 7.4B | 5.0B |
Zimmer Biomet fundamental ratios Correlations
Click cells to compare fundamentals
Zimmer Biomet Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Zimmer Biomet fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 206.7M | 207M | 210.4M | 210.3M | 209.7M | 164.9M | |
Total Assets | 24.6B | 24.4B | 23.5B | 21.1B | 21.5B | 13.7B | |
Other Current Liab | 1.9B | 1.6B | 511M | 985M | 1.3B | 941.7M | |
Total Current Liabilities | 3.4B | 2.6B | 3.5B | 2.4B | 2.9B | 1.5B | |
Total Stockholder Equity | 12.4B | 12.2B | 12.7B | 12.0B | 12.5B | 7.4B | |
Property Plant And Equipment Net | 2.1B | 2.0B | 1.8B | 1.9B | 2.3B | 1.4B | |
Accounts Payable | 400.9M | 330M | 306.5M | 354.1M | 379.8M | 228.6M | |
Non Current Assets Total | 19.9B | 19.3B | 18.6B | 16.6B | 16.9B | 10.3B | |
Non Currrent Assets Other | 980.1M | 969.4M | 2.3B | 630.8M | 559.1M | 561.5M | |
Net Receivables | 1.4B | 1.5B | 1.3B | 1.4B | 1.4B | 975.8M | |
Liabilities And Stockholders Equity | 24.6B | 24.4B | 23.5B | 21.1B | 21.5B | 13.7B | |
Non Current Liabilities Total | 8.8B | 9.7B | 7.3B | 6.7B | 6.2B | 4.8B | |
Inventory | 2.4B | 2.5B | 2.1B | 2.1B | 2.4B | 1.4B | |
Other Current Assets | 357.1M | 377.8M | 607.1M | 522.9M | 366.1M | 363.9M | |
Other Stockholder Equity | 2.2B | 2.4B | 2.6B | 2.6B | 2.3B | 2.4B | |
Total Liab | 12.2B | 12.2B | 10.8B | 9.0B | 9.0B | 6.3B | |
Property Plant And Equipment Gross | 2.1B | 2.0B | 6.1B | 6.5B | 6.8B | 7.1B | |
Total Current Assets | 4.7B | 5.1B | 4.9B | 4.4B | 4.6B | 3.4B | |
Accumulated Other Comprehensive Income | (241.9M) | (297.8M) | (231.6M) | (179.3M) | (191M) | (181.5M) | |
Other Liab | 1.9B | 2.0B | 1.9B | 1.1B | 1.3B | 1.2B | |
Other Assets | 652.9M | 969.4M | 1.1B | 1.1B | 1.3B | 1.4B | |
Property Plant Equipment | 2.1B | 2.0B | 2.0B | 1.9B | 2.2B | 1.4B | |
Short Long Term Debt Total | 8.2B | 8.1B | 7.1B | 5.7B | 6.0B | 4.3B | |
Net Debt | 7.6B | 7.3B | 6.7B | 5.3B | 5.6B | 3.7B | |
Retained Earnings | 10.4B | 10.1B | 10.3B | 9.6B | 10.4B | 6.8B | |
Cash | 617.9M | 802.1M | 378.1M | 375.7M | 415.8M | 591.2M | |
Long Term Debt | 6.7B | 7.6B | 5.5B | 5.2B | 5.0B | 4.0B | |
Cash And Short Term Investments | 617.9M | 802.1M | 378.1M | 375.7M | 415.8M | 732.9M | |
Good Will | 9.6B | 9.3B | 8.9B | 8.6B | 8.8B | 6.0B | |
Intangible Assets | 7.3B | 7.1B | 5.5B | 5.1B | 4.9B | 4.2B | |
Treasury Stock | (6.7B) | (6.7B) | (6.7B) | (6.9B) | (6.2B) | (6.5B) | |
Net Tangible Assets | (4.5B) | (4.1B) | (2.8B) | (1.6B) | (1.5B) | (1.5B) | |
Noncontrolling Interest In Consolidated Entity | 4.7M | 5.2M | 5.7M | 6.7M | 6.0M | 5.7M | |
Retained Earnings Total Equity | 10.4B | 10.1B | 10.3B | 9.6B | 11.0B | 9.1B | |
Capital Surpluse | 8.9B | 9.1B | 9.3B | 9.5B | 10.9B | 7.5B |
Currently Active Assets on Macroaxis
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Zimmer Biomet Holdings information on this page should be used as a complementary analysis to other Zimmer Biomet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Zimmer Stock analysis
When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is Zimmer Biomet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Dividend Share 0.96 | Earnings Share 4.61 | Revenue Per Share 35.889 | Quarterly Revenue Growth 0.032 |
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.